Literature DB >> 14007185

A standardized field-plot dilution test for evaluating molluscicides against amphibious Oncomelanta snails.

J E WILLIAMS, L S RITCHIE.   

Abstract

Keywords:  SNAILS/pharmacology

Mesh:

Year:  1961        PMID: 14007185      PMCID: PMC2555723     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  6 in total

1.  The biology and control of the amphibious snails that serve as intermediate hosts for Schistosoma japonicum.

Authors:  L S RITCHIE
Journal:  Am J Trop Med Hyg       Date:  1955-05       Impact factor: 2.345

2.  Repopulation control of Oncomelania nosophora by molluscicidal applications against juvenile snails through the medium of irrigation water.

Authors:  J E WILLIAMS; Y OTORI; A P MOON; L P FRICK; L S RITCHIE
Journal:  Am J Trop Med Hyg       Date:  1957-03       Impact factor: 2.345

3.  Laboratory screening of compounds for molluscicidal activity against Oncomelania nosophora with an immersion test and a modified plate test.

Authors:  A P MOON; L P FRICK; S ASAKURA
Journal:  Am J Trop Med Hyg       Date:  1958-05       Impact factor: 2.345

4.  Potential molluscacides screened in the laboratory and the results of preliminary field plot tests.

Authors:  G W HUNTER; R E FREYTAG; L S RITCHIE
Journal:  J Parasitol       Date:  1952-12       Impact factor: 1.276

5.  The use of molluscacides in the control of Oncomelania nosophora, an intermediate host of Schistosoma japonicum.

Authors:  D B McMULLEN; S KOMIYAMA; N ISHII; T ENDO-ITABASHI; K OZAWA; T ASAKAWA; Y MITOMA
Journal:  Am J Trop Med Hyg       Date:  1951-09       Impact factor: 2.345

6.  Results obtained in testing molluscacides in field plots containing Oncomelania nosophora, an intermediate host of Schistosoma japonicum.

Authors:  D B McMULLEN; S KOMIYAMA; N ISHII; T ENDO-ITABASHI; Y MITOMA
Journal:  Am J Trop Med Hyg       Date:  1951-09       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.